Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area epigenetics hypoxia inducible factors'

Search results for: 'research area epigenetics hypoxia inducible factors'

Items 21-30 of 140

Page
per page
  1. Pracinostat (SB939)
    A4095 Pracinostat (SB939)
     2 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: Pan-HDAC inhibitor
      insoluble in H2O; ≥11.4 mg/mL
  2. Belinostat (PXD101)
    A4096 Belinostat (PXD101)
     2 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: Hydroxamate-type HDAC inhibitor
      insoluble in H2O; ≥15.92 mg/mL
  3. Tubastatin A
    A4101 Tubastatin A
     6 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC6 inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥10.75 mg/mL
  4. TC-A 2317 hydrochloride
    A4489 TC-A 2317 hydrochloride
    Target: Aurora Kinases
    Summary: Aurora kinase A inhibitor,potent and selective
      <39.29 mg/mL
  5. EPZ-6438
    A8221 EPZ-6438
     5 Citation
    Summary: EZH2 inhibitor, potent and selective
      ≥28.64 mg/mL
  6. Reversine
    A3760 Reversine
    Target: Aurora Kinases
    Summary: A3 adenosine receptor antagonist,ARK-1/-2/-3 inhibitor
      insoluble in H2O; ≥19.65 mg/mL
  7. TG101348 (SAR302503)
    A4136 TG101348 (SAR302503)
     2 Citation
    Target: FLT3|JAK|c-RET
    Summary: JAK-2 inhibitor,potent and selective
      ≥26.23 mg/mL
  8. Scriptaid
    A4106 Scriptaid
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor,novel and cell-permeable
      insoluble in H2O; ≥13.1 mg/mL
  9. ENMD-2076
    A4130 ENMD-2076
    Target: Aurora Kinases|FLT3|RET|Src|VEGFR3/FLT4|NTRK1/TRKA|CSF-1R/c-Fms
    Summary: Selective Aurora A/Flt3 inhibitor
      insoluble in H2O; ≥18.75 mg/mL
  10. CCT137690
    A4132 CCT137690
    Target: Aurora Kinases
    Summary: Aurora A/B/C inhibitor
      insoluble in H2O; insoluble in EtOH; ≥6.89 mg/mL

Items 21-30 of 140

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 133item
  2. Natural Products 6item
  3. Protein 2item
  4. Peptides & Proteins 3item
  5. Lab Reagents 1 item
Specificity
  1. Selective 73item
Reversibility
  1. Reversible 5item
  2. Irreversible 3item
Target
  1. Caspases 2item
  2. Cyclin-Dependent Kinases 1 item
  3. Proteasome 1 item
  4. Histone Deacetylases (HDACs) 16item
  5. Bcl-2 1 item
  6. Raf 2item
  7. Aurora Kinases 13item
  8. Bcl-xl 1 item
  9. CSF-1R 3item
  10. EZH2 1 item
  11. Bromodomains 2item
  12. AP-1 2item
  13. MMP 2item
  14. DT-diaphorases 1 item
  15. FLT3 6item
  16. Factor Xa 4item
  17. PLK 2item
  18. VEGFR 10item
  19. PDGFR 4item
  20. c-Kit 2item
  21. RET 1 item
  22. Bromodomain-containing proteins(BRDs) 1 item
  23. Phosphodiesterases (PDEs) 1 item
  24. Mcl-1 1 item
  25. Hydrolase 1 item
  26. MEK 1 item
  27. FGFR 5item
  28. Nrf2 1 item
  29. Pim 1 item
  30. Liver X receptors (LXRs) 1 item
  31. Sir2-like Family Deacetylases (Sirtuins) 2item
  32. PP1 1 item
  33. PP2A 1 item
  34. Src 3item
  35. Trk Receptors 1 item
  36. Aminopeptidases 1 item
  37. STAT 2item
  38. Estrogen and Related Receptors 1 item
  39. EGFR 8item
  40. ROCK 1 item
  41. Hypoxia Inducible Factors (HIFs) 2item
  42. JAK 10item
  43. HSP90 1 item
  44. Topoisomerases 2item
  45. Cytochrome P450 (CYP450) 1 item
  46. ErbB 2item
  47. Toll-like receptors (TLRs) 1 item
  48. DNA Methyltransferases 1 item
  49. PKC 1 item
  50. LRRK2 1 item
  51. Insulin and Insulin-like Receptors 2item
  52. PARP 2item
  53. CB1 Receptors 1 item
  54. ALK 1 item
  55. Free Fatty Acid Receptors 1 item
  56. phosphatases 1 item
  57. Autophagy 1 item
  58. Farnesyl Diphosphate Synthases 1 item
  59. MAGL 1 item
  60. Histamine H1 Receptors 2item
  61. Hck 1 item
  62. TRP Channel 2item
  63. NO Donors / Precursors 2item
  64. CB2 Receptors 1 item
  65. Glucocorticoid Receptors 1 item
  66. IL Receptors 1 item
  67. 15-lipoxygenases 1 item
  68. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  69. Cytidine deaminases 1 item
  70. PP4 1 item
  71. c-RET 1 item
  72. FPTase 1 item
  73. VEGFR3/FLT4 1 item
  74. NTRK1/TRKA 1 item
  75. CSF-1R/c-Fms 1 item
  76. PTP 1 item
  77. p53 3item
  78. HDAC 1 item
  79. c-Fms tyrosine kinase 1 item
  80. insulin 1 item
  81. PPAR 1 item
  82. HDM2 ubiquitin ligase 1 item
  83. USP1/USF1 complex 1 item
  84. Elastases 1 item
  85. P97 ATPase 1 item
  86. Glucosidases 1 item
  87. GLI 1 item
  88. HIV 1 item
  89. Histone Acetyltransferases (HATs) 2item
  90. Telomerases 1 item
  91. Trx 1 item
  92. Tyrosinases 1 item
  93. phosphatidylinositol kinase 1 item
  94. TYK2 1 item
  95. MUSK 1 item
  96. MAP3K 1 item
  97. Lck 1 item
  98. Adenosine Deaminases 1 item
  99. p21 1 item
  100. FGR 1 item
  101. YES 1 item
  102. Fyn 1 item
  103. ARG 1 item
  104. RHA 1 item
  105. TRPC channel 1 item
  106. FKBP 1 item
  107. GLP-2 receptor 1 item
  108. Sirtuin 1 item
  109. NS3/4a Proteases 1 item
Related Disease
  1. Acute Lung Injury 1 item
  2. Acute Myeloid Leukemia 5item
  3. Bladder Cancer 4item
  4. Bladder Carcinoma 1 item
  5. Breast Cancer 18item
  6. Cancer 69item
  7. Cervical Cancer 2item
  8. Chronic Lymphocytic Leukemia 1 item
  9. Chronic Myeloproliferative Disorders 1 item
  10. Colon Cancer 4item
  11. Colorectal Cancer 6item
  12. Diabetes 1 item
  13. Glioblastoma 5item
  14. Glioma 1 item
  15. HCV 1 item
  16. HIV 1 item
  17. HIV Infections 1 item
  18. Inflammatory Diseases 1 item
  19. Leukemia 1 item
  20. Liver Cancer 2item
  21. Lung Cancer 3item
  22. Lymphoma 4item
  23. Melanoma 2item
  24. Multiple Myeloma 3item
  25. Myelofibrosis 2item
  26. Neuroblastoma 1 item
  27. Neuronal Protection 1 item
  28. Non-small Cell Lung Cancer 3item
  29. Ovarian Cancer 7item
  30. Pain Relief 1 item
  31. Pancreatic Cancer 6item
  32. Pentacyclic Triterpenoid 1 item
  33. Prostate Cancer 13item
  34. Psoriasis 1 item
  35. Pulmonary Fibrosis 1 item
  36. Renal Cancer 1 item
  37. Renal Cell Carcinoma 2item
  38. Rheumatoid Arthritis 2item
  39. Sleep Disorders 1 item
  40. Soft Tissue Sarcoma 1 item
  41. Thyroid Cancer 2item
  42. Type 2 Diabetes 1 item